鄰近類別 會議論文/會議摘要 [30/48] 專利 [0/42] 類別統計 近3年內發表的文件:13(9.15%) 含全文筆數:142(100.00%) 文件下載次數統計 下載大於0次:142(100.00%) 下載大於100次:138(97.18%) 檔案下載總次數:84136(82.42%) 最後更新時間: 2024-12-04 02:43 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Discovery of novel TANK-Binding Kin... DBPR116, a prodrug of BPRMU191, in ... Discovery of dual MER/AXL kinase in... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Influence of ring strain on the for... A dual nociceptin and mu opioid rec... Development of furanopyrimidine-bas... A critical overview of current prog... Recent advances in total synthesis ...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目51-75 / 142. (共6頁) << < 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2014-07	Anaplastic lymphoma kinase (ALK) inhibitors: A review of design and discovery	MedChemComm. 2014 Jul;5(9):1266-1279.
2014-05	Facile identification of dual FLT3-Aurora A inhibitors: A computer-guided drug design approach	ChemMedChem. 2014 May;9(5):953-961.
2014-05	Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014)	ChemMedChem. 2014 May;9(5):861.
2013-09-22	A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment [Erratum:International Journal of Biological Sciences. 2013 Apr 29;9(4):403-411]	International Journal of Biological Sciences. 2013 Sep 22;9(9):947.
2013-07-25	Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly(lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling pathway	International Journal of Nanomedicine. 2013 Jul 25;2013(8):2689-2707.
2013-06-28	Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor	Journal of Medicinal Chemistry. 2013 Jun 28;56(13):5247-5260.
2013-06	An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells	PLoS ONE. 2013 Jun;8(6):Article number e65686.
2013-05	Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
2013-05	Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors	Journal of Medicinal Chemistry. 2013 May;56(10):3889-3903.
2013-04-29	A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment	International Journal of Biological Sciences. 2013 Apr 29;9(4):403-411.
2013-02-20	Parallel screening of Wild-Type and drug-resistant targets for anti-resistance neuraminidase inhibitors	PLoS ONE. 2013 Feb 20;8(2):Article number e56704.
2013-01	3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor	ChemMedChem. 2013 Jan;8(1):136-148.
2013-01	Substituent effects on the photorearrangements of unsymmetrically substituted diazinobarrelenes	RSC Advances. 2013 Jan;3(4):1165-1178.
2012-12	An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold	Journal of the Chinese Chemical Society. 2012 Dec;59(12):1548-1554.
2012-09	Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization	ChemMedChem. 2012 Sep;7(9):1546-1550.
2012-08-24	Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts	PLoS ONE. 2012 Aug 24;7(8):Article number e43314.
2012-02	Identification of BPR3P0128 as an Inhibitor of cap-snatching activities of influenza virus	Antimicrobial Agents and Chemotherapy. 2012 Feb;56(2):647-657.
2012-01	A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors	Anticancer Research. 2012 Jan;32(1):147-151.
2011-09	Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents	European Journal of Medicinal Chemistry. 2011 Sep;46(9):3623-3629.
2011-09	Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway	Journal of Virology. 2011 Sep;85(17):9114-9126
2011-08	BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells	PLoS ONE. 2011 Aug;6(8):Article number e23485.
2011-06	Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10)	Expert Opinion on Therapeutic Patents. 2011 Jun;21(6):857-884.
2011-04-28	Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-Fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents	Journal of Medicinal Chemistry. 2011 Apr 28;54(8):3076-3080.
2011-03-07	2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors	ChemMedChem. 2011 Mar 7;6(3):450-456.
2010-10-28	Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and michael acceptor group for maximal potency	Journal of Medicinal Chemistry. 2010 Oct 28;53(20):7316-7326.

顯示項目51-75 / 142. (共6頁) << < 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目